Literature DB >> 17534937

Distribution of 26RFa binding sites and GPR103 mRNA in the central nervous system of the rat.

Federica Bruzzone1, Benoît Lectez, David Alexandre, Sylvie Jégou, Lourdes Mounien, Hélène Tollemer, David Chatenet, Jérôme Leprince, Mauro Vallarino, Hubert Vaudry, Nicolas Chartrel.   

Abstract

The novel RFamide peptide 26RFa, the endogenous ligand of the orphan receptor GPR103, affects food intake, locomotion, and activity of the gonadotropic axis. However, little is known regarding the localization of 26RFa receptors. The present report provides the first detailed mapping of 26RFa binding sites and GPR103 mRNA in the rat central nervous system (CNS). 26RFa binding sites were widely distributed in the brain and spinal cord, whereas the expression of GPR103 mRNA was more discrete, notably in the midbrain, the pons, and the medulla oblongata, suggesting that 26RFa can bind to a receptor(s) other than GPR103. Competition experiments confirmed that 26RFa interacts with an RFamide peptide receptor distinct from GPR103 that may be NPFF2. High densities of 26RFa binding sites were observed in olfactory, hypothalamic, and brainstem nuclei involved in the control of feeding behavior, including the piriform cortex, the ventromedial and dorsomedial hypothalamic nuclei, the paraventricular nucleus, the arcuate nucleus, the lateral hypothalamic area, and the nucleus of the solitary tract. The preoptic and anterior hypothalamic areas were also enriched with 26RFa recognition sites, supporting a physiological role of the neuropeptide in the regulation of the gonadotropic axis. A high density of 26RFa binding sites was detected in regions of the CNS involved in the processing of pain, such as the dorsal horn of the spinal cord and the parafascicular thalamic nucleus. The wide distribution of 26RFa binding sites suggests that 26RFa has multiple functions in the CNS that are mediated by at least two distinct receptors. (c) 2007 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17534937     DOI: 10.1002/cne.21400

Source DB:  PubMed          Journal:  J Comp Neurol        ISSN: 0021-9967            Impact factor:   3.215


  19 in total

Review 1.  The Arg-Phe-amide peptide 26RFa/glutamine RF-amide peptide and its receptor: IUPHAR Review 24.

Authors:  Jérôme Leprince; Didier Bagnol; Ronan Bureau; Shoji Fukusumi; Riccarda Granata; Shuji Hinuma; Dan Larhammar; Stefany Primeaux; Jana Sopkova-de Oliveiras Santos; Kazuyoshi Tsutsui; Kazuyoshi Ukena; Hubert Vaudry
Journal:  Br J Pharmacol       Date:  2017-09-08       Impact factor: 8.739

2.  A review of FMRFamide- and RFamide-like peptides in metazoa.

Authors:  Robert J Walker; Sylvana Papaioannou; Lindy Holden-Dye
Journal:  Invert Neurosci       Date:  2010-02-26

3.  New Hits as Antagonists of GPR103 Identified by HTS.

Authors:  Anneli Nordqvist; Lisbeth Kristensson; Kjell E Johansson; Krystle Isaksson da Silva; Tomas Fex; Christian Tyrchan; Anette Svensson Henriksson; Kristina Nilsson
Journal:  ACS Med Chem Lett       Date:  2014-02-22       Impact factor: 4.345

4.  Study of the role of novel RF-amide neuropeptides in affecting growth hormone secretion in a representative non-human primate (Macaca mulatta).

Authors:  Fatima Qaiser; Fazal Wahab; Muhammad Amin Wiqar; Rizwan Hashim; Jerome Leprince; Hubert Vaudry; Manuel Tena-Sempere; Muhammad Shahab
Journal:  Endocrine       Date:  2012-04-22       Impact factor: 3.633

5.  QRFP in female rats: effects on high fat food intake and hypothalamic gene expression across the estrous cycle.

Authors:  Stefany D Primeaux
Journal:  Peptides       Date:  2011-04-05       Impact factor: 3.750

6.  The 26RFa (QRFP)/GPR103 neuropeptidergic system in mice relays insulin signalling into the brain to regulate glucose homeostasis.

Authors:  Mouna El Mehdi; Saloua Takhlidjt; Mélodie Devère; Arnaud Arabo; Marie-Anne Le Solliec; Julie Maucotel; Alexandre Bénani; Emmanuelle Nedelec; Céline Duparc; Benjamin Lefranc; Jérôme Leprince; Youssef Anouar; Gaëtan Prévost; Nicolas Chartrel; Marie Picot
Journal:  Diabetologia       Date:  2022-04-27       Impact factor: 10.122

7.  Molecular basis of agonist docking in a human GPR103 homology model by site-directed mutagenesis and structure-activity relationship studies.

Authors:  C Neveu; F Dulin; B Lefranc; L Galas; C Calbrix; R Bureau; S Rault; J Chuquet; J A Boutin; L Guilhaudis; I Ségalas-Milazzo; D Vaudry; H Vaudry; J Sopkova-de Oliveira Santos; J Leprince
Journal:  Br J Pharmacol       Date:  2014-09-05       Impact factor: 8.739

8.  Hypothalamic QRFP: regulation of food intake and fat selection.

Authors:  S D Primeaux; M J Barnes; H D Braymer
Journal:  Horm Metab Res       Date:  2013-08-26       Impact factor: 2.936

9.  QRFP and Its Receptors Regulate Locomotor Activity and Sleep in Zebrafish.

Authors:  Audrey Chen; Cindy N Chiu; Eric A Mosser; Sohini Kahn; Rory Spence; David A Prober
Journal:  J Neurosci       Date:  2016-02-10       Impact factor: 6.167

10.  Role of neuropeptide FF in central cardiovascular and neuroendocrine regulation.

Authors:  Jack H Jhamandas; Valeri Goncharuk
Journal:  Front Endocrinol (Lausanne)       Date:  2013-02-07       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.